Cranbury New Jersey based Outlook Therapeutics is raising $7,971,155.00 in New Equity Investment.
Cranbury, NJ – According to filings with the U.S. Securities and Exchange Commission, Outlook Therapeutics is raising $7,971,155.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Lawrence Kenyon played a…